Brain Tumor Treatment in Hyderabad — Expert Neuro-Oncology Care Across 7 Locations

Brain Tumors in Hyderabad — What You Need to Know

The brain controls everything — movement, speech, memory, personality — and the idea of cancer in that space is deeply unsettling. At CION Cancer Clinics, our neuro-oncology team delivers expert brain tumor care from molecular testing that guides treatment, to stereotactic radiosurgery for metastatic lesions, to the full Stupp protocol for glioblastoma — across 7 Hyderabad locations, backed by NABH accreditation.

What follows is a complete, jargon-translated guide to how brain tumors are classified, the tests that change treatment plans, the modern surgical and radiation options, and the realistic outcomes you can expect. Written and reviewed by our neuro-oncology team for patients and families navigating a brain tumor diagnosis in Hyderabad.

Primary and Secondary Brain Tumors — Two Very Different Situations

When people hear "brain tumor," they often assume cancer that started in the brain. In reality, the majority of brain tumors treated by oncologists are secondary — cancer that started elsewhere and has spread to the brain. The distinction is essential because the treatment approach is completely different.

How Brain Tumors Are Classified — WHO Grades, Not Cancer Stages

Brain tumors are not described using the Stage I to Stage IV system most people associate with cancer. Instead, they are given a WHO grade — based on how aggressive the tumor cells look under a microscope. The grade, not a stage, determines treatment urgency and approach.

The 2021 WHO classification of brain tumors is largely based on molecular markers including IDH status — which is why grade alone no longer tells the full picture. See the molecular testing section below.

Common Types of Primary Brain Tumors We Treat

Not all primary brain tumors behave the same way. CION's tumor board evaluates every diagnosis at the histological and molecular level so treatment is tailored precisely to the subtype.

Who Is at Risk of Brain Tumors?

For primary brain tumors, the causes are largely unknown in most patients. Established risk factors are few:

• Previous high-dose radiation to the head — the strongest established environmental risk factor; can occur years or decades after radiation treatment for other conditions
• Rare inherited genetic conditions — neurofibromatosis types 1 and 2, Li-Fraumeni syndrome, tuberous sclerosis, von Hippel-Lindau disease; uncommon but carry significantly elevated brain tumor risk
• Age — glioblastoma is most common after 60; many low-grade gliomas appear in adults aged 30–50; medulloblastoma is primarily a childhood tumor
• Mobile phone radiation — despite widespread concern, large-scale studies have not established a clear link between mobile phone use and brain tumor risk

For secondary brain tumors (brain metastases), the risk depends on having an advanced primary cancer — particularly lung, breast, kidney, melanoma, or colon cancer. Any patient with advanced cancer who develops new neurological symptoms should be evaluated for brain metastases.

Symptoms of a Brain Tumor

Symptoms depend on the location of the tumor in the brain. Because different parts of the brain control different functions, a tumor in the speech area causes different symptoms from one in the movement area. General warning signs include:

• Progressively worsening headaches — particularly headaches that are worst in the morning, wake the person from sleep, or are accompanied by nausea and vomiting; not all brain tumor headaches are severe
• Seizures — a new seizure in an adult with no prior history is a medical emergency and should prompt immediate brain imaging; this is a common first presentation of brain tumors
• Weakness or numbness on one side of the body — affecting the arm, leg, or face
• Speech problems — difficulty finding words, slurring, or difficulty understanding what others say
• Vision changes — double vision, blurred vision, loss of part of the visual field
• Balance and coordination problems — difficulty walking, frequent falls, unsteady gait
• Personality or cognitive changes — memory problems, confusion, changes in behaviour or personality that others notice before the patient does

Red flag: A first adult seizure with no prior history always requires urgent brain MRI. Early diagnosis gives the best surgical options. Speak to a CION neuro-oncologist if you or someone you know has these symptoms.

How Is a Brain Tumor Diagnosed at CION?

CION's diagnostic pathway integrates advanced imaging and biopsy where required to confirm the diagnosis, identify the exact tumor type, and provide the molecular information needed to plan treatment.

MRI Brain with Contrast

MRI is the gold standard for diagnosing and characterising brain tumors. An MRI with gadolinium contrast shows the tumor's location, size, relationship to critical brain structures, and characteristics that suggest whether it is likely to be benign or malignant. Specialised MRI sequences — including perfusion MRI, spectroscopy, and functional MRI — provide additional information about blood flow within the tumor, its metabolic activity, and its proximity to speech and movement areas.

CT Scan

A CT scan is faster than MRI and is used in emergency situations — for example, when a patient presents with a sudden new seizure or deteriorating consciousness. CT reliably detects large tumors, bleeding around the tumor, and bone involvement.

Biopsy — Essential for Definitive Diagnosis

Imaging suggests a brain tumor but only a tissue biopsy can confirm the diagnosis, identify the exact tumor type, and provide the molecular information needed to plan treatment. Biopsy is performed either as part of surgical resection (the most common approach) or as a stereotactic needle biopsy — a minimally invasive procedure where a needle is guided to the tumor using imaging, without opening the skull widely. At CION, biopsy samples are sent for standard histological analysis and molecular testing.

The Test That Changes Everything — Molecular Testing for Brain Tumors

No local hospital treatment page in Hyderabad currently explains this — but for any patient with a malignant brain tumor, the molecular test results from the biopsy are as important as the surgery itself. Two specific tests directly determine treatment planning and prognosis:

IDH Mutation Testing

IDH (isocitrate dehydrogenase) is an enzyme; a mutation in the IDH gene is found in about 80% of lower-grade gliomas and a smaller proportion of glioblastomas. IDH mutation status is the single most powerful prognostic marker in glioma. IDH-mutated gliomas grow more slowly, respond better to treatment, and have significantly longer survival than IDH wild-type tumors at the same grade. The 2021 WHO classification of brain tumors is largely based on molecular markers including IDH status — which is why grade alone no longer tells the full picture.

MGMT Promoter Methylation Testing

MGMT is a DNA repair gene. In glioblastoma, if the MGMT gene is "methylated" (switched off), the tumor is much more sensitive to temozolomide chemotherapy — the standard drug used alongside radiation for GBM. Patients with MGMT-methylated GBM have a median survival of approximately 23 months with the standard Stupp protocol, compared to about 12 to 14 months for unmethylated tumors. Knowing MGMT status at diagnosis is essential for informed decision-making about chemotherapy — and for discussing realistic expectations with patients and families. CION arranges MGMT and IDH testing as standard on all biopsy samples from malignant gliomas.

Brain Tumor Surgery in Hyderabad — Maximum Safe Removal

Surgery is the first treatment for most accessible brain tumors. The goal is to remove as much of the tumor as possible — called maximum safe resection — while preserving brain function. The extent of surgical removal is one of the strongest predictors of survival for high-grade gliomas.

Craniotomy with Neuronavigation

The standard brain tumor operation involves removing a section of the skull to access the tumor, guided by a neuronavigation system — a real-time GPS for the brain that uses pre-operative MRI images to guide the surgeon's instruments to the exact tumor location while avoiding critical structures. Neuronavigation significantly reduces the risk of damaging important brain tissue during surgery.

Awake Craniotomy — Surgery with the Patient Awake

For brain tumors located in or near the areas that control speech, language, or movement, there is a safer alternative to conventional surgery under full general anaesthesia: awake craniotomy.

Here is what it involves: the patient is given sedation and local anaesthetic for the first part of the operation — the skull opening. Once the brain is exposed (the brain itself has no pain receptors), the patient is gently woken up and asked to perform tasks — talking, naming objects, moving their hand or foot — while the surgeon uses gentle electrical stimulation to map which areas of the exposed brain are responsible for these functions. The tumor is then removed while the patient's responses are continuously monitored: if stimulating an area causes a problem (the patient suddenly cannot speak, or their hand movement weakens), the surgeon knows to stop and avoid that spot. The patient is then sedated again while the skull is closed.

The result is that awake craniotomy achieves more complete tumor removal in tumors near speech and movement areas — because the surgeon can work right up to the functional boundary — while causing less damage to surrounding brain tissue than conventional surgery. Patients typically wake up speaking normally within hours of the operation. The procedure sounds alarming but is well tolerated with proper preparation and skilled anaesthetic support.

Radiation Therapy for Brain Tumors

Standard IMRT to the Brain

For high-grade gliomas (Grade 3 and 4), radiation therapy is delivered after surgery — targeting the area around the tumor to destroy remaining cancer cells. Precision radiation techniques — IMRT (intensity-modulated radiation therapy) — shape the radiation beam to the tumor cavity and surrounding margin, reducing dose to normal brain tissue. Treatment runs over 6 weeks, 5 days per week.

Stereotactic Radiosurgery in Hyderabad — Radiation Without Open Surgery

Stereotactic radiosurgery (SRS) is one of the most important tools in modern brain tumor treatment — and one of the least understood by patients and families. Despite the name "radiosurgery," no cutting is involved. SRS uses multiple highly focused radiation beams that converge from different angles simultaneously on a precise point — the tumor — delivering a high dose exactly there while the surrounding brain receives very little radiation. From outside the body, the procedure looks like a CT scanner. The patient lies still while the beams are delivered. There is no incision, no general anaesthesia, no hospital admission for most cases, and no recovery period.

SRS is used in two main situations for brain tumors:

• For primary brain tumors that are small, deep, or in locations too risky for open surgery — benign tumors like meningiomas, acoustic neuromas, and pituitary tumors; selected Grade 2 gliomas in critical areas; recurrent tumors after previous surgery
• For brain metastases — when cancer from another part of the body has spread to the brain, SRS can treat multiple lesions precisely and quickly, often avoiding the need for whole-brain radiation and the cognitive effects associated with it

SRS is typically completed in 1 to 5 sessions. For lesions up to about 3cm in diameter, it achieves excellent local tumor control. CION's radiation oncology team plans SRS treatments using detailed MRI-based planning to precisely define the target and protect the surrounding brain.

Glioblastoma Treatment in Hyderabad — The Stupp Protocol Explained

Glioblastoma is the most aggressive primary brain cancer, and understanding the treatment sequence helps patients and families know what to expect. The standard approach — called the Stupp protocol, named after the clinical trial that established it — involves three phases:

1. 1
   Surgery — the neurosurgeon removes as much of the tumor as safely possible while the patient is monitored with neuronavigation; MGMT and IDH testing is performed on the removed tissue.
2. 2
   Concurrent chemoradiation (6 weeks) — daily radiation to the brain area, 5 days a week for 6 weeks, simultaneously with a daily oral chemotherapy tablet called temozolomide; the two together are significantly more effective than radiation alone; patients typically feel well enough to continue light activities during this phase.
3. 3
   Adjuvant chemotherapy (6 months) — after the chemoradiation, monthly cycles of temozolomide for 6 months, typically 5 days on and 23 days off per cycle; blood counts are monitored regularly.

After completion of the Stupp protocol, regular MRI brain scans are performed every 2 to 3 months to monitor for recurrence. The first MRI after chemoradiation can be difficult to interpret — a phenomenon called "pseudoprogression" can make the scan look worse than it is, due to post-treatment inflammation rather than true tumor growth. Experienced neuro-oncologists recognise this and avoid premature changes to the treatment plan.

Brain Metastases — When Cancer From Elsewhere Spreads to the Brain

For many patients — particularly those with advanced lung, breast, kidney, or melanoma cancer — the brain is a site of spread. Brain metastases are more common than all primary brain tumors combined. They require a different approach from primary brain cancer.

The primary treatment for brain metastases has shifted dramatically in recent years. Stereotactic radiosurgery — delivering focused radiation to each individual lesion without open surgery — is now the preferred treatment for most patients with a limited number of brain metastases. Modern guidelines support treating multiple lesions with SRS, avoiding the cognitive side effects of whole-brain radiation. SRS typically takes 1 to 3 sessions and is done as an outpatient.

When does surgery play a role in brain metastases? Surgery is considered when a single large lesion is causing significant pressure or symptoms, when a biopsy is needed to confirm the diagnosis, or when the primary cancer type is unknown and tissue confirmation is required.

The systemic treatment for brain metastases — immunotherapy, targeted therapy, or chemotherapy — is coordinated by CION's medical oncology team alongside the management of the primary cancer.

Multidisciplinary Tumour Board — Every Brain Tumor Case Reviewed Together

Brain tumor management is among the most complex in oncology. Surgery, radiation, medical oncology, and often neurology must work together from the beginning. At CION, every brain tumor case is reviewed by our multidisciplinary team before any treatment plan is finalised:

• MRI brain reviewed by neuro-oncology specialists — WHO grade, location, proximity to eloquent areas, surgical feasibility
• Molecular testing (IDH, MGMT) arranged at biopsy — prognosis assessed, temozolomide response predicted
• Awake craniotomy evaluated for tumors in speech or motor areas — maximising safe resection
• SRS vs standard radiation vs whole-brain radiation decision for brain metastases
• Stupp protocol initiated for GBM — concurrent temozolomide and radiation coordination
• Antiepileptic medicine management coordinated (many brain tumor patients have seizures)
• Steroid management — to reduce brain swelling during and after treatment
• Rehabilitation planning — speech therapy, physiotherapy, and cognitive rehabilitation after surgery or radiation
• Palliative and supportive care for GBM — quality of life and symptom control are central to the management plan
• NCCN and ESMO protocol adherence
• Digital coordination across all 7 Hyderabad locations

Why Patients Choose CION for Brain Tumor Treatment in Hyderabad

Eleven reasons our patients pick CION for neuro-oncology — across volume, surgical and radiation expertise, molecular testing, and supportive care.

Brain Cancer Treatment Cost in Hyderabad

Costs vary significantly depending on whether surgery, radiation, chemotherapy, or a combination is required:

Costs are indicative. A personalised cost estimate is provided following your initial neuro-oncology consultation at CION.

Financial Support Options

• EMI Facility — flexible instalment-based payment options available for all patients.
• Private Health Insurance — CION works with all major TPAs for cashless hospitalisation.

Brain Tumor Care Near You — In Hyderabad & Beyond

CION operates 35+ centres across Telangana and Andhra Pradesh. Find your nearest brain tumor specialist or explore care options in your city.

Brain Tumor Care in Hyderabad — by Location

Brain Tumor Care Beyond Hyderabad

Travelling for treatment? We may have a centre right where you are — across Telangana and Andhra Pradesh.

Not seeing your city? Call 18002028726 — we'll connect you to the nearest CION centre or arrange a teleconsultation.

Not Sure About Your Treatment Plan?

Get a free written second opinion from CION's neuro-oncology tumor board — particularly valuable before surgery, or if molecular testing (IDH, MGMT) hasn't been arranged.

Frequently Asked Questions

Common questions about brain tumor treatment in Hyderabad — answered by CION's neuro-oncology team.

Disclaimer: This content is intended for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified oncologist for guidance specific to your medical condition. The information on this page is periodically reviewed and updated by CION's medical team in accordance with current clinical guidelines.